Table of Contents
ALLEGAN, Mich., and MONMOUTH JUNCTION, N.J. — Perrigo Co. and Tris Pharma Inc. have launched of a store-brand version of the over-the-counter cough medicine Delsym.
The companies said Monday that their new product is equivalent to Delsym extended-release oral liquid suspension, containing dextromethorphan polistirex, and will be marketed under major U.S. retailer and wholesalers’ store brands or own-label brands.
"We are excited to partner with Tris Pharma and bring this first-ever store brand extended-release liquid cough/cold product to our retail and store-brand customers’ portfolios in time for the season," commented Joseph Papa, chairman and chief executive officer of Perrigo. "This launch continues to demonstrate our commitment to making quality health care more affordable for consumers."
Delsym, indicated for the temporary treatment of cough due to minor throat and bronchial irritation, has estimated annual sales of $100 million, Perrigo and Tris Pharma reported.
"When we developed our proprietary technology to deliver drugs in taste-neutral, extended-release dosage forms such as liquids and ODT/chewable tablets, we were focused on improving the profile of new drugs," Tris Pharma CEO Ketan Mehta stated. "However, Delsym presented a unique opportunity where we were able to leverage our technology to bring a long overdue, lower-cost alternative to consumers, and I am delighted we were able to partner with Perrigo to do so."
